Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Four types of Tregs in malignant lymphomas
Jing Wang, Xiaoyan Ke
Journal of Hematology & Oncology (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM)
Sylvia Feyler, Peter J. Selby, Gordon Cook
Blood Reviews (2013) Vol. 27, Iss. 3, pp. 155-164
Closed Access | Times Cited: 32
Novel agents for chronic lymphocytic leukemia
Mei‐Hwan Wu, Akintunde Akinleye, Xiongpeng Zhu
Journal of Hematology & Oncology (2013) Vol. 6, Iss. 1
Open Access | Times Cited: 31
Regulatory T Cells in Allogeneic Stem Cell Transplantation
Maria Michael, Avichai Shimoni, Arnon Nagler
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-9
Open Access | Times Cited: 31
Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma
Haiyan Hao, Ziheng Wang, Shiqi Ren, et al.
PeerJ (2019) Vol. 7, pp. e8205-e8205
Open Access | Times Cited: 27
Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment
Christina Hadjiaggelidou, Eirini Katodritou
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4588-4588
Open Access | Times Cited: 22
Clinical and Immunological Effects of p53-Targeting Vaccines
Shan Zhou, Chunmei Fan, Zhaoyang Zeng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 20
Homozygous A polymorphism of the complement C1qA 276 correlates with prolonged overall survival in patients with diffuse large B cell lymphoma treated with R-CHOP
Xuan Jin, Huirong Ding, Ning Ding, et al.
Journal of Hematology & Oncology (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 28
T-cell lymphoma: Microenvironment-related biomarkers
Eric Tse, Yok‐Lam Kwong
Seminars in Cancer Biology (2015) Vol. 34, pp. 46-51
Closed Access | Times Cited: 26
Increased regulatory T cells in acute lymphoblastic leukaemia patients
Siti-Zuleha Idris, Norfarazieda Hassan, Le-Jie Lee, et al.
Hematology (2016) Vol. 21, Iss. 4, pp. 206-212
Open Access | Times Cited: 24
Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19
Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
Daniel Ren Yi Yap, Jing Quan Lim, Dachuan Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The Complex Relationship between Mechanisms Underlying Inflammatory Bowel Disease, Its Treatment, and the Risk of Lymphomas: A Comprehensive Review
Katarzyna Stasik, Rafał Filip
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4241-4241
Open Access | Times Cited: 2
The density of CD8+ T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone
Hajnalka Rajnai, Fenna H. Heyning, Lianne Koens, et al.
Virchows Archiv (2013) Vol. 464, Iss. 2, pp. 229-239
Closed Access | Times Cited: 25
Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma
Marwa M. Serag El-Dien, Asmaa Gaber Abdou, Nancy Y. Asaad, et al.
Applied immunohistochemistry & molecular morphology (2016) Vol. 25, Iss. 8, pp. 534-542
Closed Access | Times Cited: 22
CXCR4 and CCR7 Expression in Primary Nodal Diffuse Large B-Cell Lymphoma—A Clinical and Immunohistochemical Study
Hui Du, Li Zhang, Guangyao Li, et al.
The American Journal of the Medical Sciences (2019) Vol. 357, Iss. 4, pp. 302-310
Closed Access | Times Cited: 20
Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
Joana Rodrigues, Anna Nikkarinen, Peter Hollander, et al.
British Journal of Haematology (2021) Vol. 193, Iss. 3, pp. 520-531
Open Access | Times Cited: 17
The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4683-4683
Open Access | Times Cited: 17
Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma
Mehdi Dehghani, Mehdi Kalani, Hossein Golmoghaddam, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1917-1928
Closed Access | Times Cited: 17
Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells
Amir Hossein Mansourabadi, Leila Mohamed Khosroshahi, Farshid Noorbakhsh, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107669-107669
Closed Access | Times Cited: 13
On the learning control effects in the cancer-immune system competition
Léon Masurel, Carlo Bianca, A. Lemarchand
Physica A Statistical Mechanics and its Applications (2018) Vol. 506, pp. 462-475
Open Access | Times Cited: 15
Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients
Eren Gündüz, Serap Sermet, Ahmet Musmul
Cytometry Part B Clinical Cytometry (2015) Vol. 90, Iss. 5, pp. 449-454
Open Access | Times Cited: 14
Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
Lijuan Deng, Yuqin Song, Jun Zhu, et al.
International Journal of Hematology (2013) Vol. 98, Iss. 6, pp. 664-671
Closed Access | Times Cited: 14
Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients
Franz Buchegger, Steven M. Larson, Jean‐Pierre Mach, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-8
Open Access | Times Cited: 13
Autoimmunity and Lymphoma: A Brief Review
Miller Edward B
Journal of Rheumatic Diseases and Treatment (2018) Vol. 4, Iss. 2
Open Access | Times Cited: 13
Role of Microenvironment in Non-Hodgkin Lymphoma
Arushi Khurana, Stephen M. Ansell
The Cancer Journal (2020) Vol. 26, Iss. 3, pp. 206-216
Closed Access | Times Cited: 12

Scroll to top